(Q46879563)

English

Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

1 reference

based on heuristic

inferred from title

author name string

Dehlink E

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Eiwegger T

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Gerstmayr M

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Kampl E

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Bohle B

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Chen KW

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Vrtala S

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Urbanek R

8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Szépfalusi Z

9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

publication date

1 January 2006

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

36

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

32-39

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Sublingual immunotherapy for allergic rhinoconjunctivitis--the seeming and the real

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02400.X

21 January 2018

Identifiers

10.1111/J.1365-2222.2006.02400.X

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16393263

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46879563&oldid=2135615241"